World Health Organization (WHO) informs on the official website about the publication of List № 124-COVID-19 (special edition) (https://www.who.int/medicines/publications/druginformation/innlists/PL12...) which refers to International Nonproprietary Names proposed for Pharmaceutical Substances (INN).

Any comments that may be made, or notifications of a conflict between proposed names and existing proprietary rights, should be addressed to the INN Programme to the INN Programme of the World Health Organization within four months of the date of their publication in WHO Drug Information, i.e., for List no. 124-COVID-19 (special edition) of Proposed INN not later than 22 February 2021.